GGrantIndex
Sort

172,184 grants matching inflammation

Middle Ear Pressure Regulation in Health and Disease

$1,281,917
William J Doyle · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · DC

Use of a Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel

$1,281,780
Mark Cisneros · Nutrabiotix, Llc · R44 · FY2014 · DK

Novel Prebiotic Fiber as Targeted Dietary Management of Irritable Bowel Syndrome

$1,281,780
Mark Cisneros · Nutrabiotix, Llc · R44 · FY2013 · DK

Mechanisms of Chronic Inflammation in Periodontitis

$1,281,727
Niki Moutsopoulos · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE

Oral Microbial and Immunological Characterization of Patients with Immune Dysfun

$1,281,727
Niki Moutsopoulos · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE

Endocannabinoid Active Sites as Therapeutic Targets

$1,281,665
Alexandros Makriyannis · Northeastern University · P01 · FY2014 · DA

Prophylaxis of adrenal insufficiency to prevent CLD

$1,281,530
University Of New Mexico · R01 · FY2001 · HD

UAB Diabetes Research Center

$1,281,325
W Timothy Garvey · University Of Alabama At Birmingham · P30 · FY2024 · DK

UAB Diabetes Research Center

$1,281,325
Ananda Basu · University Of Alabama At Birmingham · P30 · FY2025 · DK

UAB Diabetes Research Center

$1,281,325
W Timothy Garvey · University Of Alabama At Birmingham · P30 · FY2023 · DK

Center for Biomedical OCT Research and Translation

$1,281,121
Brett E Bouma · Massachusetts General Hospital · P41 · FY2019 · EB

Center for Biomedical OCT Research and Translation

$1,281,012
Brett E Bouma · Massachusetts General Hospital · P41 · FY2020 · EB

Investigating the interactions between viral infection, Tau pathology, and neuroinflammation

$1,281,004
Kristen Emily Funk · University Of North Carolina Charlotte · RF1 · FY2023 · AG

Cardiovascular Status of HAART-Exposed Infants/Children

$1,280,662
University Of Rochester · R01 · FY2002 · HL

First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)

$1,280,437
Eti Yoles · Immunobrain Checkpoint Inc. · R01 · FY2023 · AG

Adhesion and Migration in Inflammation

$1,280,006
Keith Burridge · Univ Of North Carolina Chapel Hill · P01 · FY2008 · HL

Deciphering the Genomics of Gene Network Regulation of T Cell and Fibroblast States in Autoimmune Inflammation

$1,280,000
Christina S Leslie · Sloan-Kettering Inst Can Research · U01 · FY2022 · HG

Deciphering the Genomics of Gene Network Regulation of T Cell and Fibroblast States in Autoimmune Inflammation

$1,280,000
Christina S Leslie · Sloan-Kettering Inst Can Research · U01 · FY2021 · HG

Deciphering the Genomics of Gene Network Regulation of T Cell and Fibroblast States in Autoimmune Inflammation

$1,280,000
Christina S Leslie · Sloan-Kettering Inst Can Research · U01 · FY2023 · HG

Elucidating the basis of brain control of innate immune responses

$1,279,747
Hao Jin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Design And Development Of Experimental Therapeutics

$1,279,633
Nigel H. Greig · National Institute On Aging · ZIA · FY2015 · AG

Clinical and Molecular Epidemiology of High Risk Coronary Plaque

$1,279,576
Svati H. Shah · Duke University · R01 · FY2021 · HL

New York Columbia Collaborative SPOTRIAS

$1,279,480
Randolph S Marshall · Columbia University Health Sciences · P50 · FY2011 · NS

DEMYELINATING DISEASE: VIRAL AND IMMUNE FUNCTION

$1,279,136
Stephen A. Stohlman · Cleveland Clinic Lerner Com-Cwru · P01 · FY2006 · NS

Developing AI-Driven Pain Intensity and Pain Sensitization Biomarker Signatures to Optimize Neonatal Pain Management

$1,278,689
Yu Sun · University Of South Florida · UG3 · FY2024 · NS